Immune checkpoint inhibitors for POLE or POLD1 proofreading-deficient metastatic colorectal cancer. - Ambrosini, M.; Rousseau, B.; Manca, P.; Artz, O.; Marabelle, A.; André, T.; Maddalena, G.; Mazzoli, G.; Intini, R.; Cohen, R.; Cercek, A.; Segal, N.H.; et al. (Annals of Oncology, 2024)